SKI Market

Indian Indices

Sensex

80,015.90 899.71
( 1.14%)

Global Indices

Nasdaq

48,766.17 243.89
(0.50%)

Dow Jones

6,891.51 53.88
(0.79%)

Hang Seng

55,141.42 895.88
(1.65%)

Nikkei 225

10,568.52 84.39
(0.80%)

Forex

USD-INR

91.96 0.48
(0.52%)

EUR-INR

106.94 -0.34
(-0.32%)

GBP-INR

122.70 0.09
(0.07%)

JPY-INR

0.58 0.00
(0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hikal Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524735

INE475B01022

96.8412723

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HIKAL

91.5

2290.31

EPS(TTM)

Face Value()

Div & Yield %

2.03

0.43

Back

Board of Bliss GVS Pharma recommends interim dividend

Feb 10,2026

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 10 February 2026, inter alia, have recommended the interim dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

80,015.90 899.71 ( 1.14%)

48,766.17 243.89 (0.50%)

6,891.51 53.88 (0.79%)

55,141.42 895.88 (1.65%)

10,568.52 84.39 (0.80%)

91.96 0.48 (0.52%)

106.94 -0.34 (-0.32%)

122.70 0.09 (0.07%)

0.58 0.00 (0.18%)